CCR5 and colorectal carcinoma: TAM complexity is paving a possibly way for the design of novel TAM-targeting therapies to harness their anti-tumoral potential [103], e.g., through CCR5-inhibitor treatment reprogramming TAMs toward a pro-inflammatory phenotype in metastatic CRC patients [104].